AzTrials
AzTrials

Smoking CessationNCT03194958

Helping Poor Smokers Quit

A study testing Specialized Quitline and Basic Needs Navigator in people with Smoking Cessation and Smoking, Tobacco, run by Washington University School of Medicine at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Using a 2x2 randomized factorial design, we will conduct a statewide field trial in Missouri to compare the relative and combined effects of these two strategies for augmenting an existing, evidence-based tobacco quitline program. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Specialized Quitline and Basic Needs Navigator
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,944 participants
Where
1 siteUnited States
Study dates
5 Jun 2017to 1 Jul 2022
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 years and older
  • Missouri resident
  • English speaking
  • Not in crisis
  • Smoke cigarettes every day of the week
  • Planning to quit smoking in the next 30 days
  • Comfortable receiving calls from smoking expert and project team
  • Willing to provide phone numbers to be reached

Who cannot join

  • Pregnant or planning to become pregnant in the next 3 months
  • Currently breastfeeding
  • Insurance through employer
  • Currently enrolled in smoking quitline

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Washington University in St. Louis

    St Louis, Missouri, 63130

Other trials in United States

About this study

Official title: Helping the Poor Quit Smoking: Specialized Quitlines and Meeting Basic Needs

Using a 2x2 randomized factorial design, we will conduct a statewide field trial in Missouri to compare the relative and combined effects of these two strategies for augmenting an existing, evidence-based tobacco quitline program. Among 2000 low-income smokers, half will receive standard Missouri quitline services and half will receive new Specialized Quitline services targeted to this group. In each of these groups, half also will receive calls from a trained navigator to help them address unmet Basic Needs and the accompanying psychological distress that act as barriers to smoking cessation.

Read the detailed description

2-1-1 information specialists will deliver standard service, then ask a random number of callers per day if they would be willing to answer a few health questions as part of a new 2-1-1 service. Callers eligible to receive the invitation to screen for study eligibility will be: Missouri residents, calling for themselves, English-speaking, and not in acute crisis. Eligible smokers will then be asked if they are willing to share their contact information with a research team conducting a study to help smokers quit. Smokers who agree to share their contact information will be considered "enrolled". Trained 2-1-1 operators will record all recruitment screening data in a secure electronic database that is shared with research staff. Research staff will attempt to reach enrolled smokers by phone by the next business day.

Alere, through the Missouri Tobacco Quitline, will provide quitline services to smokers in all study conditions. Contact information and study group assignment for smokers will be provided to Alere via secure data transfer.

Being tested
Specialized Quitline, Basic Needs Navigator
Medical subject headings
Smoking Cessation, Tobacco Smoking, Cigarette Smoking, Pipe Smoking, Smoking, Behavior, Addictive, Tobacco Use, Tobacco Use Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Specialized QuitlineBehavioural

    Very low-income smokers are different from other smokers in important ways not always addressed by standard quitline services. The research team and Alere staff has created custom protocols, scripts, prompts and other content to maximize intervention relevance and acceptability to very low-income smokers. Research Implementation Unit (RIU) coaches who will be delivering the Specialized Quitline services have received training from clinical quitline staff, the research team and 2-1-1 staff who have extensive experience with the target population. Focus areas for training and distinctive content and protocol for the Specialized Quitline include: health literacy, abstract vs. concrete language, lived experience, resource constraints, future orientation, getting cigarettes, living situation, phone/internet access.

  • Basic Needs NavigatorBehavioural

    Navigators will: (1) identify and assess smokers' needs, including the reasons they called 2-1-1; (2) jointly generate solutions to address the needs; (3) develop plans to carry out the solutions, including; (4) help prioritize among multiple needs; (5) identify community resources that could help solve the problem; (6) determine eligibility for services; (7) help smokers access available resources by scheduling appointments and provide appointment reminders; (8) prepare smokers to interact with service agencies and/or act as an advocate on their behalf; (9) provide instrumental support such as arranging transportation; (10) actively intervene to resolve barriers to basic needs solutions; (11) oversee follow-up of problem solving actions; and (12) review progress made towards resolving unmet basic needs and adapt solutions accordingly.

Study groups in NCT03194958
Study groupRoleWhat they receive
Standard QuitlineNo interventionParticipants will receive standard Missouri quitline services
Specialized QuitlineExperimentalParticipants will receive an enhanced version of the standard quitline services
Receives: Behavioral: Specialized Quitline
Standard Quitline with Basic Needs NavigatorExperimentalParticipants receive standard quitline services with navigator
Receives: Behavioral: Basic Needs Navigator
Specialized Quitline with Basic Needs NavigatorExperimentalParticipants receive enhanced quitline services with navigator
Receives: Behavioral: Specialized Quitline; Behavioral: Basic Needs Navigator

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Abstinence 6-months

    Report 7-day point prevalence abstinence measured at 6-months post --baseline

    Measured: 6 months post-baseline

Secondary outcomes (2)
  1. Abstinence 3-months

    Report 7-day point prevalence abstinence measured at 3-months post-baseline

    Measured: 3 months post-baseline

  2. 24hr Quit Attempt

    Report quitting smoking for at least 24 hours during intervention

    Measured: 6 months post-baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2017
  2. Study start5 Jun 2017
  3. Primary completion1 Jul 2022
  4. Study completion1 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
1,944 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03194958
Sponsor's protocol ID
R01CA201429
Other IDs
R01CA201429
Status last verified
Dec 2023
First submitted
19 Jun 2017
Last updated
26 Dec 2023
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Boyum S, Kreuter MW, McQueen A, Thompson T, Greer R. Getting help from 2-1-1: A statewide study of referral outcomes. J Soc Serv Res. 2016;42(3):402-411. doi: 10.1080/01488376.2015.1109576. Epub 2016 Jan 22.

    PubMed 28260823
  • Cappelletti ER, Kreuter MW, Boyum S, Thompson T. Basic needs, stress and the effects of tailored health communication in vulnerable populations. Health Educ Res. 2015 Aug;30(4):591-8. doi: 10.1093/her/cyv033.

    PubMed 26187910
  • Kreuter MW, McQueen A, Boyum S, Fu Q. Unmet basic needs and health intervention effectiveness in low-income populations. Prev Med. 2016 Oct;91:70-75. doi: 10.1016/j.ypmed.2016.08.006. Epub 2016 Aug 3.

    PubMed 27496395
  • Thompson T, Kreuter MW, Boyum S. Promoting Health by Addressing Basic Needs: Effect of Problem Resolution on Contacting Health Referrals. Health Educ Behav. 2016 Apr;43(2):201-7. doi: 10.1177/1090198115599396. Epub 2015 Aug 20.

    PubMed 26293458
  • Zanis DA, Hollm RE, Derr D, Ibrahim JK, Collins BN, Coviello D, Melochick JR. Comparing intervention strategies among rural, low SES, young adult tobacco users. Am J Health Behav. 2011 Mar-Apr;35(2):240-7. doi: 10.5993/ajhb.35.2.11.

    PubMed 21204686
  • Richter KP, Shireman TI, Ellerbeck EF, Cupertino AP, Catley D, Cox LS, Preacher KJ, Spaulding R, Mussulman LM, Nazir N, Hunt JJ, Lambart L. Comparative and cost effectiveness of telemedicine versus telephone counseling for smoking cessation. J Med Internet Res. 2015 May 8;17(5):e113. doi: 10.2196/jmir.3975.

    PubMed 25956257
  • Ferketich AK, Pennell M, Seiber EE, Wang L, Farietta T, Jin Y, Wewers ME. Provider-delivered tobacco dependence treatment to Medicaid smokers. Nicotine Tob Res. 2014 Jun;16(6):786-93. doi: 10.1093/ntr/ntt221. Epub 2014 Jan 28.

    PubMed 24474305
  • Bush T, Levine MD, Beebe LA, Cerutti B, Deprey M, McAfee T, Boeckman L, Zbikowski S. Addressing weight gain in smoking cessation treatment: a randomized controlled trial. Am J Health Promot. 2012 Nov-Dec;27(2):94-102. doi: 10.4278/ajhp.110603-QUAN-238.

    PubMed 23113779
  • Smith SS, Keller PA, Kobinsky KH, Baker TB, Fraser DL, Bush T, Magnusson B, Zbikowski SM, McAfee TA, Fiore MC. Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant. Nicotine Tob Res. 2013 Mar;15(3):718-28. doi: 10.1093/ntr/nts186. Epub 2012 Sep 19.

    PubMed 22992296
  • Perry RJ, Keller PA, Fraser D, Fiore MC. Fax to quit: a model for delivery of tobacco cessation services to Wisconsin residents. WMJ. 2005 May;104(4):37-40, 44.

    PubMed 16117232
  • Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD002850. doi: 10.1002/14651858.CD002850.pub2.

    PubMed 16855992
  • Fiore MC. US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care. 2000 Oct;45(10):1200-62.

    PubMed 11054899
  • Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD000165. doi: 10.1002/14651858.CD000165.pub4.

    PubMed 23728631
  • Bryant J, Bonevski B, Paul C, McElduff P, Attia J. A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups. Addiction. 2011 Sep;106(9):1568-85. doi: 10.1111/j.1360-0443.2011.03467.x. Epub 2011 Jul 22.

    PubMed 21489007
  • Lichtenstein E, Glasgow RE, Lando HA, Ossip-Klein DJ, Boles SM. Telephone counseling for smoking cessation: rationales and meta-analytic review of evidence. Health Educ Res. 1996 Jun;11(2):243-57. doi: 10.1093/her/11.2.243.

    PubMed 10163409

Questions about this trial

What is this clinical trial studying?

A study testing Specialized Quitline and Basic Needs Navigator in people with Smoking Cessation and Smoking, Tobacco, run by Washington University School of Medicine at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 26 Dec 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Abstinence 6-months (time frame: 6 months post-baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03194958, which also lists 169 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Dec 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in